Clinical trials for sale: inVentiv Group files for an IPO that could raise $500 million

inVentiv Group Holdings, one of the largest global contract research organizations which provides clinical development and commercialization services, filed on Tuesday with the SEC to raise up to $100 million, likely a placeholder for an IPO we estimate could raise up to $500 million.

The Burlington, MA-based company was founded in 1999. It has not selected an exchange or symbol. Credit Suisse, Morgan Stanley, Goldman Sachs, Jefferies, Citi, BofA Merrill Lynch, Barclays and Wells Fargo are the joint bookrunners on the deal. No pricing terms were disclosed.